EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Associations of elevated cardiac biomarkers with hyperuricemia and mortality in US adults without prevalent cardiovascular disease

Haitao Xie, Le Shen, Peng Yu, Shi Wang, Tong Sun, Xueqian Liu, Mengxi Wang, Li Qian, Jiayi Hua, Nan Chen, Xiaohu Chen, Shuhua Tang

Frontiers in Endocrinology · 2024

DOI: 10.3389/fendo.2024.1432200 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Endocrinology, 2024. Verfasst von Haitao Xie und 11 weiteren Autor:innen. Beteiligte Einrichtung: First Clinical Medical College, Nanjing University of Chinese Medicine, Nanjing, China. Hauptthemen laut MEDLINE: Hyperuricemia, Biomarkers, Cardiovascular Diseases, Peptide Fragments. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

NT-proBNP (N-terminal pro-B-type natriuretic peptide), high-sensitivity cardiac troponin T (hs-troponin T), and high-sensitivity cardiac troponin I (hs-troponin I) have been widely recognized as significant cardiac biomarkers, and are increasingly being recommended for early risk identification in cardiovascular high-risk populations. The aim of our study was to evaluate the prevalence of elevated cardiac biomarkers (NT-proBNP, hs-troponin T, hs-troponin I) and their association with the risk of hyperuricemia in the general US adults without known cardiovascular disease. We further studied whether elevated cardiac biomarkers are associated with an increased risk of all-cause and cardiovascular mortality in individuals with or without hyperuricemia.

Methods

The study population came from the adults (age ≥20y) without prevalent cardiovascular disease in NHANES (National Health and Nutrition Examination Survey) 1999 to 2004. We evaluated the prevalence of elevated cardiac biomarkers among adults with or without hyperuricemia, and conducted a comprehensive multivariate logistic regression analysis to ascertain the association between elevated cardiac biomarkers and hyperuricemia risk. Multivariate Cox regression model and Kaplan-Meier curve, risk competition model and Cumulative Incidence Function(CIF) were used respectively to examine the associations between elevated cardiac biomarkers with all-cause and cardiovascular mortality.

Results

In general US adults without known cardiovascular disease, the prevalence of hyperuricemia was 16.35%. The age-adjustd prevalence of elevated NT-proBNP (≥125 pg/mL), hs-troponin T (≥6 ng/L), and hs-troponin I (male ≥6, female ≥4 ng/L) was 16.70%, 49.80%, and 11.91%, respectively, among adults with hyperuricemia. Adjusted multivariable logistic regression analysis revealed a statistically significant association between elevated levels of NT-proBNP, hs-troponin T, and hs-troponin I and hyperuricemia, and different clinical categories observed grade differences on the same cardiac biomarker. Elevated NT-proBNP, hs-troponinT and hs-troponinI were each significantly positively associated with the cumulative incidence of all-cause and cardiovascular mortality in adults with or without hyperuricemia. Compared to those with elevated cardiac biomarkers only, adults with hyperuricemia and elevated cardiac biomarkers faced the highest risk of all-cause and cardiovascular mortality.

Conclusions

Our study identified that elevated cardiac biomarkers pose a high burden on hyperuricemia risk in the general population without known cardiovascular disease, and further provides important information on long-term mortality risk in these populations. Routine testing of cardiac biomarkers may be useful for early risk identification and prognostic assessment in adults with hyperuricemia.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HyperuricemiaBiomarkersCardiovascular DiseasesPeptide FragmentsNatriuretic Peptide, BrainTroponin THumansMaleFemaleMiddle AgedAdultUnited StatesTroponin INutrition SurveysPrevalenceAgedRisk Factors

Stichwörter der Autor:innen

cardiac biomarkershyperuricemiapopulation studyprevalencerisk of mortalitywithout known cardiovascular disease

Substanzen

BiomarkersPeptide FragmentsNatriuretic Peptide, Brainpro-brain natriuretic peptide (1-76)Troponin TTroponin I

Autor:innen und Institutionen

  • First Clinical Medical College, Nanjing University of Chinese Medicine, Nanjing, China.
  • Department of Cardiology, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, China.
  • Department of Cardiology, Jiangsu Province Hospital of Chinese Medicine, Nanjing, China.
  • First Clinical Medical College, Nanjing Medical University, Nanjing, China.

Zitieren

APA

Xie, H., Shen, L., Yu, P., Wang, S., Sun, T., Liu, X., Wang, M., Qian, L., Hua, J., Chen, N., Chen, X., & Tang, S. (2024). Associations of elevated cardiac biomarkers with hyperuricemia and mortality in US adults without prevalent cardiovascular disease. Frontiers in Endocrinology. https://doi.org/10.3389/fendo.2024.1432200

Vancouver

Xie H, Shen L, Yu P, Wang S, Sun T, Liu X, et al. Associations of elevated cardiac biomarkers with hyperuricemia and mortality in US adults without prevalent cardiovascular disease. Frontiers in Endocrinology. 2024. doi:10.3389/fendo.2024.1432200

BibTeX
@article{Xie2024,
  author = {Xie, Haitao and Shen, Le and Yu, Peng and Wang, Shi and Sun, Tong and Liu, Xueqian and Wang, Mengxi and Qian, Li and Hua, Jiayi and Chen, Nan and Chen, Xiaohu and Tang, Shuhua},
  title = {Associations of elevated cardiac biomarkers with hyperuricemia and mortality in US adults without prevalent cardiovascular disease},
  journal = {Frontiers in Endocrinology},
  year = {2024},
  doi = {10.3389/fendo.2024.1432200}
}
Kostenlos starten →